Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07078461 · ClinicalTrials.gov registry record · NA
Investigating the Safety and Efficacy of the 1927-nm Thulium Laser in Keratosis Pilaris
A NA study of Keratosis Pilaris (KP), sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT07078461 is a NA study of Keratosis Pilaris (KP) that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 25 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07078461, a NA study of Keratosis Pilaris (KP), is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
Keratosis pilaris (KP) is a very common skin condition that affects up to 80% of adolescents and 40% of adults. Clinically, KP causes rough dry patches and tiny spiny bumps around the hair follicles, as well as redness and pigmentation changes, most often on the upper arms, thighs, cheeks, or buttocks. While KP is benign, it can be cosmetically very bothersome. Currently, treatment options for KP are limited, and consist of topical moisturizers and keratolytic agents, but often leads to suboptimal improvements. In literature, many laser treatment modalities for KP have been studied, with varying results. The primary aim of this pilot study is to investigate how KP, a predominantly follicular disorder, responds to treatment with the 1927-nm Thulium laser.
Conditions Studied
Interventions
- DEVICE 1927-nm Thulium Laser therapy
Study Locations (1)
Maryland
- Johns Hopkins University - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2025-10-23 |
| Est. Completion | 2026-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07078461
The ClinicalTrials.gov registry entry for NCT07078461 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Keratosis Pilaris (KP) appearing as the primary indexed condition, and to 1 intervention - of which 1927-nm Thulium Laser therapy is the first listed.
NCT07078461 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT07078461 about?
NCT07078461 is a clinical study titled "Investigating the Safety and Efficacy of the 1927-nm Thulium Laser in Keratosis Pilaris". Keratosis pilaris (KP) is a very common skin condition that affects up to 80% of adolescents and 40% of adults. Clinically, KP causes rough dry patches and tiny spiny bumps around the hair follicles, as well as redness and pigmentation changes, most often on the upper arms, thighs, cheeks, or buttoc...
What is the current status of trial NCT07078461?
This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2025-10-23. Estimated completion is 2026-12.
What conditions does trial NCT07078461 study?
This clinical trial studies the following conditions: Keratosis Pilaris (KP).
What interventions are being tested in trial NCT07078461?
The interventions under investigation include: 1927-nm Thulium Laser therapy (DEVICE).
Who is sponsoring clinical trial NCT07078461?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07078461 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.